1 / 25

Polio Eradication

Polio Eradication. Dr Marvin Hsiao Division of Medical Virology NHLS/UCT/Groote Schuur Hospital. The virus. Single strand positive sense RNA virus Non-enveloped Family Picornaviridae Genus Enterovirus 3 types, poliovirus 1-3 Grows well in cell culture. The pathogenesis.

valentine-perkins
Télécharger la présentation

Polio Eradication

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Polio Eradication Dr Marvin Hsiao Division of Medical Virology NHLS/UCT/Groote Schuur Hospital

  2. The virus • Single strand positive sense RNA virus • Non-enveloped • Family Picornaviridae • Genus Enterovirus • 3 types, poliovirus 1-3 • Grows well in cell culture

  3. The pathogenesis • Faecal oral transmission (+respiratory) • Replicate in the lymphoid tissue in throat and gut - Viraemia • Replication in neuronal cell – especially motor neuron in spinal cord (polios: grey muelos: marrow) • Lytic infection of neurons • Anterior horn cell • Axon degeneration • LMN (flaccid) paralysis

  4. The disease Adapted from Collier & Oxford Human Virology 2nd Edition Poliovirus infection asymptomatic Mild Febrile Illness Full recovery Meningitic Stage Post polio syndrome Acute Flaccid Paralysis (+/-1%) Death

  5. The vaccines

  6. The vaccines *VAPP = Vaccine associated paralytic poliomyelitis

  7. Levels of epidemiological modification by vaccination

  8. The campaign • 1988 World Health Assembly passed a resolution to eradicate polio by 2000 • The Global Polio Eradication Initiative was founded – Biggest Public health initiative to date • Task: co-ordinate eradication of poliovirus globally and source funding

  9. Global Status 1988 http://www.polioeradication.org/ 350 000 cases polio-1988 125 polio-endemic countries

  10. Global Status 2004 http://www.polioeradication.org 1,263 cases in 2004 (99% reduction in cases) 1000 childhood paralysis prevented per day 6 polio-endemic countries, 5 countries re-established transmission

  11. Science 26 March 2005 vol 303

  12. The challenges • Funding gap • Containing polio in endemic area • Nigeria • Uttar Pradesh and Bihar states in NE India • Containing polio epidemics due to importation (Namibia) • Vaccine derived polio viruses (VDPV) • Laboratory containment

  13. Polio endemic area • Nigeria • Overcoming political and religious resistence • Vaccination campaign back on track • India • High intensity of polio transmission combined with high incidence of enteric disease • Despite good coverage unable to interrupt transmission of polio • Monovalent vaccine (response to single dose mOPV is >75% compare to tOPV 25%)

  14. The Namibian experience • Prior to the outbreak • Started OPV 1990, coverage of 60-80% • Last case of polio reported 1996 • AFP surveillance: 2.6/100,000 and 86% stool collection rate (adequate) • The outbreak: • Index case May 2006 • 185 suspected cases • 20 laboratory confirmed cases • 21 deaths, ¾ are adult over 15 years • Gaps in immunisation – a number of susceptible adults

  15. The Namibian experience • Virus identified as poliovirus type 1 SOAS genotype • Same strain as Angolan outbreak and NE states of India • Molecular distance compare to parental strain is approximately 2.5 year • Unclear whether imported from Angola or India

  16. The Namibian experience • Massive immunisation campaign targeting the entire population. • Three national immunisation days. • > 2 million doses of monovalent OPV1 administered • Outbreak halted

  17. The Namibian experience • Lessons learned: • Coverage needs to be >80% -Immunisation gap • Importance of disease surveillance • Traditional AFP surveillance on children <15 yo is inadequate marker of polio elimination • Importance of laboratory network and regional reference laboratory • Constant risk of importation • Political will – immunisation campaigns

  18. VDPV (Vaccine derived polio virus) OPV genome • <1% VP1 genetic divergence = vaccine strain (Sabin-like virus) • 1-15% VP1 genetic divergence = • Vaccine derive polio virus (VDPV) • cVDPV (evidence of circulation in the communities) • iVDPV (chronically shed by immunocompromised individuals) • >15% VP1 genetic divergence = wild polio virus 99 85

  19. The laboratory containment • A country cannot be certified as polio free unless all laboratories are free of poliovirus • If 1 country is not certified polio free, polio cannot be eradicated • Potential sources polio outbreak: • Stored stool specimen, past poliovirus isolates, polio vaccine manufacturing facility • Past enteric pathogen research specimen • Past environmental surveillance (water) samples • Past respiratory specimen (routine/research) • The “mystery” vial / Legacy of previous research in the –70 freezer

  20. Is it possible to eradicate polio? • It is possible and it has to be done • Prevent re-emergence of polio we need to: • Keep vaccinating with routine EPI and various campaigns • Good acute flaccid paralysis surveillance • Rid the laboratory of wild and vaccine poliovirus • Stop using OPV in the final phase of polio eradication • Thank you

More Related